CTOs on the Move

Tandem Labs

www.tandemlabs.com

 
Tandem Labs is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Tandem Labs is based in Salt Lake City, UT. You can find more information on Tandem Labs at www.tandemlabs.com
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tandemlabs.com
  • 1121 E 3900 S Ste c105
    Salt Lake City, UT USA 84124
  • Phone: 801.293.2400

Executives

Name Title Contact Details

Similar Companies

Mills-Peninsula Health Services

Mills-Peninsula Health Services is a Burlingame, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Veterans Evaluation Services

Veterans Evaluation Services is a company that supports the U.S. Department of Veterans Affairs in providing veterans and transitioning service members with the benefits theyve earned through their service to the country. They provide high quality, ti...

Medicom Health Interactive

Medicom Health Interactive is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Minneapolis, MN. To find more information about Medicom Health Interactive, please visit www.medicomhealth.com

Hannibal Regional Hospital

Hannibal Regional Hospital Foundation is a non-profit corporation (501,(c)3) and a part of the Hannibal Regional Healthcare System which exists to support Hannibal Regional Hospital by raising privately donated money.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.